GCG and Stroke: There is a growing body of evidence suggesting that GLP1-RA may reduce mortality and cardiovascular outcomes, including fatal or non-fatal MI and stroke in T2D patients, beyond their beneficial effect on glycemic control (Kristensen et al., 2019).